Survival of Neoadjuvant and Adjuvant Therapy Compared With Surgery Alone for Resectable Esophageal Squamous Cell Carcinoma: A Systemic Review and Network Meta-Analysis.

Front Oncol · 2021 · PMC8564474 · PMID 34745950

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginally significantno p-value reported

Adjuvant therapy failed to show a survival benefit compared with surgery alone, though ACRT showed a marginally significant survival advantage and ranked second in the ranking analysis.

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.